Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapyYi Bao, Arul M. Chinnaiyan, Ilona Kryczek et al.|Proceedings of the National Academy of Sciences|2023Cited by 31